Nivolumab Plus Cabozantinib in Non–Clear Cell RCC
David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.
Source: onclive.com
Clear Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clear Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clear Cell Today - Breaking & Trending Today
KEYNOTE-B61: Lenvatinib Plus Pembrolizumab in Non–Clear Cell RCC
Focusing on the KEYNOTE-B61 trial evaluating lenvatinib plus pembrolizumab in the first line, a panel of medical oncologists react to clinical trial data on combination regimens in non–clear cell renal cell carcinoma.
Source: onclive.com
Overview of Non–Clear Cell RCC
The expert panel gives an overview of non–clear cell renal cell carcinoma, highlighting disease subtypes and treatment approaches.
Source: onclive.com
cc-TDI and Atomwise Forge Global AI Collaboration in Cancer Research
The Children's Cancer Therapy Development Institute (cc-TDI), proudly announces a global Artificial Intelligence (AI) collaboration with Atomwise, resulting in a new publication in the journal Scientific Reports.
Source: azorobotics.com
Experts Discuss Current Standards, Selection, and Uncertainties in Bladder and Renal Cancer Care
Experts delineate the latest developments and lingering questions in bladder and renal cancers, covering pivotal trials, emerging therapies, and optimal management approaches.
Source: onclive.com